Statistics

Total Visits

Views
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial21

Select a period of time:

Number of views in the range

Views
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial14

Views

Views
May 20244
June 20240
July 20243
August 20240
September 20246
October 20240
November 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
United Kingdom2
 

Top cities views

Views
Chicago3
Fort Worth2